As per the bulk deal information with the bourses, PCR Investments, which held 18.42 per cent at the end of September quarter, today bought 10 lakh shares of Apollo Hospitals.
Apollo Hospitals shares were purchased for an average price of Rs 876.67 apiece valuing the transaction at Rs 87.67 crore.
In the quarter ended September 2013, PCR Investments held 2.56 crore shares of Apollo Hospitals representing a stake of 18.42 per cent in the company.
Shares of Apollo Hospitals rose by 2.86 per cent to end the day at Rs 875.25 apiece on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
